Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use o...
Gespeichert in:
| Veröffentlicht in: | Sultan Qaboos University medical journal 2021-02, Vol.21 (1), p.103-109 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 109 |
|---|---|
| container_issue | 1 |
| container_start_page | 103 |
| container_title | Sultan Qaboos University medical journal |
| container_volume | 21 |
| creator | Al-Baimani , Khalid Hamid , Rana S Al-Moundhri , Mansour S D'souza , Philomena C Al-Sukaiti , Rashid Kumar , Shiyam Kakaria , Annupam Mittal , Alok K Burney , Ikram A Al-Balushi , Muna |
| description | Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the
safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns
of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer
treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the
researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer
treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic
features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the
port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of
devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most
frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for
patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related
infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical
stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism
isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P |
| doi_str_mv | 10.18295/squmj.2021.21.01.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_alman</sourceid><recordid>TN_cdi_almanhal_primary_234256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2621048790</sourcerecordid><originalsourceid>FETCH-LOGICAL-a353t-8dba31e4337400a59c066a0cce5dfc062bbcde9c607f26c7a8ba881c1610ffe3</originalsourceid><addsrcrecordid>eNpdUU1r3DAQFaWlCdv8hBZBL73sVh-WZF8KwaRNICU5bEtvYizLiRZb2kh2YM_945Wz6W5aMaBB8-Zp5j2E3lOyoiWrxOf0MA2bFSOMrnKQOYpX6JQRJZZEsPL1Iae_TtBZShuSDy-VpOItOuFcKVVwcop-12HY9s7A6IJPGHyLv4OHOztYP-LQ4XUYoe93-CrDwI_Q9BbXuRahxz-tD1PC58bYlPBtiGPCzuMavLER32bODMykIwb8w7tHG5Mbd_gypK3LrDP2ZgD_Dr3poE_27PleoPXXi3V9uby--XZVn18vgQs-Lsu2AU5tkYcvCAFRGSIlkPy5aLucs6Yxra2MJKpj0igoGyhLaqikpOssX6Ave9rt1Ay2Nfsl9Da6AeJOB3D634p39_ouPGpVybIiKhN8eiaI4WGyadSDS8b2WRebddBMECmIEFnoBfr4H3QTpujzdppJRklRqmpGiT3KxJBStN1hGEr0k9H6yWg9G61zkDmK3Pfh5SaHrr-2HgE2v9sOjry8qKSiRwD02YD7FzIwXjAh-R9_zbxy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621048790</pqid></control><display><type>article</type><title>Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman</title><source>MEDLINE</source><source>PubMed Central</source><creator>Al-Baimani , Khalid ; Hamid , Rana S ; Al-Moundhri , Mansour S ; D'souza , Philomena C ; Al-Sukaiti , Rashid ; Kumar , Shiyam ; Kakaria , Annupam ; Mittal , Alok K ; Burney , Ikram A ; Al-Balushi , Muna</creator><creatorcontrib>Al-Baimani , Khalid ; Hamid , Rana S ; Al-Moundhri , Mansour S ; D'souza , Philomena C ; Al-Sukaiti , Rashid ; Kumar , Shiyam ; Kakaria , Annupam ; Mittal , Alok K ; Burney , Ikram A ; Al-Balushi , Muna</creatorcontrib><description>Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the
safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns
of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer
treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the
researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer
treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic
features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the
port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of
devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most
frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for
patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related
infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical
stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism
isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05).
On multivariate analysis, however, none of the factors was found to be significant. Conclusion: Infection was the most
common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’
previous experience and compares favorably with several published reports.</description><identifier>ISSN: 2075-051X</identifier><identifier>EISSN: 2075-0528</identifier><identifier>DOI: 10.18295/squmj.2021.21.01.014</identifier><identifier>PMID: 33777430</identifier><language>eng</language><publisher>Muscat - Oman: Sultan Qaboos Uinversity : Academic Publication Board</publisher><subject>Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - therapeutic use ; BLOOD VESSELS ; Body mass index ; Breast cancer ; Cancer therapies ; Catheter-Related Infections - etiology ; Catheterization, Central Venous - adverse effects ; CATHETERS ; Chemotherapy ; Clinical & Basic Research ; Colorectal cancer ; CRABS ; Female ; Follow-Up Studies ; Gastric cancer ; Hospitals ; Hospitals, University ; Humans ; INFECTION ; Jugular Veins - surgery ; Male ; Neoplasms - drug therapy ; Nosocomial infections ; OMAN ; Patients ; Prosthesis-Related Infections - etiology ; Retrospective Studies ; Sepsis - etiology ; Thrombosis ; Vascular Access Devices - adverse effects ; Vascular Access Devices - microbiology ; Venous access ; أوعية الدم ; السرطان ; العدوى ; القثطار ; عمان</subject><ispartof>Sultan Qaboos University medical journal, 2021-02, Vol.21 (1), p.103-109</ispartof><rights>Copyright 2021, Sultan Qaboos University Medical Journal, All Rights Reserved.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2021, Sultan Qaboos University Medical Journal, All Rights Reserved 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a353t-8dba31e4337400a59c066a0cce5dfc062bbcde9c607f26c7a8ba881c1610ffe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttps://static.almanhal.com/covers/titl/234256/cover-lg.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33777430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Baimani , Khalid</creatorcontrib><creatorcontrib>Hamid , Rana S</creatorcontrib><creatorcontrib>Al-Moundhri , Mansour S</creatorcontrib><creatorcontrib>D'souza , Philomena C</creatorcontrib><creatorcontrib>Al-Sukaiti , Rashid</creatorcontrib><creatorcontrib>Kumar , Shiyam</creatorcontrib><creatorcontrib>Kakaria , Annupam</creatorcontrib><creatorcontrib>Mittal , Alok K</creatorcontrib><creatorcontrib>Burney , Ikram A</creatorcontrib><creatorcontrib>Al-Balushi , Muna</creatorcontrib><title>Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman</title><title>Sultan Qaboos University medical journal</title><addtitle>Sultan Qaboos Univ Med J</addtitle><description>Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the
safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns
of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer
treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the
researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer
treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic
features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the
port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of
devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most
frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for
patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related
infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical
stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism
isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05).
On multivariate analysis, however, none of the factors was found to be significant. Conclusion: Infection was the most
common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’
previous experience and compares favorably with several published reports.</description><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>BLOOD VESSELS</subject><subject>Body mass index</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Catheter-Related Infections - etiology</subject><subject>Catheterization, Central Venous - adverse effects</subject><subject>CATHETERS</subject><subject>Chemotherapy</subject><subject>Clinical & Basic Research</subject><subject>Colorectal cancer</subject><subject>CRABS</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastric cancer</subject><subject>Hospitals</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>INFECTION</subject><subject>Jugular Veins - surgery</subject><subject>Male</subject><subject>Neoplasms - drug therapy</subject><subject>Nosocomial infections</subject><subject>OMAN</subject><subject>Patients</subject><subject>Prosthesis-Related Infections - etiology</subject><subject>Retrospective Studies</subject><subject>Sepsis - etiology</subject><subject>Thrombosis</subject><subject>Vascular Access Devices - adverse effects</subject><subject>Vascular Access Devices - microbiology</subject><subject>Venous access</subject><subject>أوعية الدم</subject><subject>السرطان</subject><subject>العدوى</subject><subject>القثطار</subject><subject>عمان</subject><issn>2075-051X</issn><issn>2075-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdUU1r3DAQFaWlCdv8hBZBL73sVh-WZF8KwaRNICU5bEtvYizLiRZb2kh2YM_945Wz6W5aMaBB8-Zp5j2E3lOyoiWrxOf0MA2bFSOMrnKQOYpX6JQRJZZEsPL1Iae_TtBZShuSDy-VpOItOuFcKVVwcop-12HY9s7A6IJPGHyLv4OHOztYP-LQ4XUYoe93-CrDwI_Q9BbXuRahxz-tD1PC58bYlPBtiGPCzuMavLER32bODMykIwb8w7tHG5Mbd_gypK3LrDP2ZgD_Dr3poE_27PleoPXXi3V9uby--XZVn18vgQs-Lsu2AU5tkYcvCAFRGSIlkPy5aLucs6Yxra2MJKpj0igoGyhLaqikpOssX6Ave9rt1Ay2Nfsl9Da6AeJOB3D634p39_ouPGpVybIiKhN8eiaI4WGyadSDS8b2WRebddBMECmIEFnoBfr4H3QTpujzdppJRklRqmpGiT3KxJBStN1hGEr0k9H6yWg9G61zkDmK3Pfh5SaHrr-2HgE2v9sOjry8qKSiRwD02YD7FzIwXjAh-R9_zbxy</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Al-Baimani , Khalid</creator><creator>Hamid , Rana S</creator><creator>Al-Moundhri , Mansour S</creator><creator>D'souza , Philomena C</creator><creator>Al-Sukaiti , Rashid</creator><creator>Kumar , Shiyam</creator><creator>Kakaria , Annupam</creator><creator>Mittal , Alok K</creator><creator>Burney , Ikram A</creator><creator>Al-Balushi , Muna</creator><general>Sultan Qaboos Uinversity : Academic Publication Board</general><general>Sultan Qaboos University, College of Medicine and Health Sciences</general><general>Sultan Qaboos University</general><general>Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences</general><scope>~6Z</scope><scope>ADJCN</scope><scope>ADTGW</scope><scope>AGZBS</scope><scope>AHFXO</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210201</creationdate><title>Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman</title><author>Al-Baimani , Khalid ; Hamid , Rana S ; Al-Moundhri , Mansour S ; D'souza , Philomena C ; Al-Sukaiti , Rashid ; Kumar , Shiyam ; Kakaria , Annupam ; Mittal , Alok K ; Burney , Ikram A ; Al-Balushi , Muna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a353t-8dba31e4337400a59c066a0cce5dfc062bbcde9c607f26c7a8ba881c1610ffe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>BLOOD VESSELS</topic><topic>Body mass index</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Catheter-Related Infections - etiology</topic><topic>Catheterization, Central Venous - adverse effects</topic><topic>CATHETERS</topic><topic>Chemotherapy</topic><topic>Clinical & Basic Research</topic><topic>Colorectal cancer</topic><topic>CRABS</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastric cancer</topic><topic>Hospitals</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>INFECTION</topic><topic>Jugular Veins - surgery</topic><topic>Male</topic><topic>Neoplasms - drug therapy</topic><topic>Nosocomial infections</topic><topic>OMAN</topic><topic>Patients</topic><topic>Prosthesis-Related Infections - etiology</topic><topic>Retrospective Studies</topic><topic>Sepsis - etiology</topic><topic>Thrombosis</topic><topic>Vascular Access Devices - adverse effects</topic><topic>Vascular Access Devices - microbiology</topic><topic>Venous access</topic><topic>أوعية الدم</topic><topic>السرطان</topic><topic>العدوى</topic><topic>القثطار</topic><topic>عمان</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Baimani , Khalid</creatorcontrib><creatorcontrib>Hamid , Rana S</creatorcontrib><creatorcontrib>Al-Moundhri , Mansour S</creatorcontrib><creatorcontrib>D'souza , Philomena C</creatorcontrib><creatorcontrib>Al-Sukaiti , Rashid</creatorcontrib><creatorcontrib>Kumar , Shiyam</creatorcontrib><creatorcontrib>Kakaria , Annupam</creatorcontrib><creatorcontrib>Mittal , Alok K</creatorcontrib><creatorcontrib>Burney , Ikram A</creatorcontrib><creatorcontrib>Al-Balushi , Muna</creatorcontrib><collection>Al Manhal All Journals Collection</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>قاعدة العلوم الاقتصادية والمالية وإدارة الأعمال - e-Marefa Economics, Finance & Business Administration</collection><collection>قاعدة العلوم الاجتماعية - e-Marefa Social Sciences</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Sultan Qaboos University medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Baimani , Khalid</au><au>Hamid , Rana S</au><au>Al-Moundhri , Mansour S</au><au>D'souza , Philomena C</au><au>Al-Sukaiti , Rashid</au><au>Kumar , Shiyam</au><au>Kakaria , Annupam</au><au>Mittal , Alok K</au><au>Burney , Ikram A</au><au>Al-Balushi , Muna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman</atitle><jtitle>Sultan Qaboos University medical journal</jtitle><addtitle>Sultan Qaboos Univ Med J</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>21</volume><issue>1</issue><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>2075-051X</issn><eissn>2075-0528</eissn><abstract>Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the
safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns
of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer
treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the
researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer
treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic
features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the
port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of
devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most
frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for
patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related
infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical
stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism
isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05).
On multivariate analysis, however, none of the factors was found to be significant. Conclusion: Infection was the most
common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’
previous experience and compares favorably with several published reports.</abstract><cop>Muscat - Oman</cop><pub>Sultan Qaboos Uinversity : Academic Publication Board</pub><pmid>33777430</pmid><doi>10.18295/squmj.2021.21.01.014</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2075-051X |
| ispartof | Sultan Qaboos University medical journal, 2021-02, Vol.21 (1), p.103-109 |
| issn | 2075-051X 2075-0528 |
| language | eng |
| recordid | cdi_almanhal_primary_234256 |
| source | MEDLINE; PubMed Central |
| subjects | Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use BLOOD VESSELS Body mass index Breast cancer Cancer therapies Catheter-Related Infections - etiology Catheterization, Central Venous - adverse effects CATHETERS Chemotherapy Clinical & Basic Research Colorectal cancer CRABS Female Follow-Up Studies Gastric cancer Hospitals Hospitals, University Humans INFECTION Jugular Veins - surgery Male Neoplasms - drug therapy Nosocomial infections OMAN Patients Prosthesis-Related Infections - etiology Retrospective Studies Sepsis - etiology Thrombosis Vascular Access Devices - adverse effects Vascular Access Devices - microbiology Venous access أوعية الدم السرطان العدوى القثطار عمان |
| title | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_alman&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complications%20and%20Management%20of%20Totally%20Implantable%20Central%20Venous%20Access%20Ports%20in%20Cancer%20Patients%20at%20a%20University%20Hospital%20in%20Oman&rft.jtitle=Sultan%20Qaboos%20University%20medical%20journal&rft.au=Al-Baimani%20,%20Khalid&rft.date=2021-02-01&rft.volume=21&rft.issue=1&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=2075-051X&rft.eissn=2075-0528&rft_id=info:doi/10.18295/squmj.2021.21.01.014&rft_dat=%3Cproquest_alman%3E2621048790%3C/proquest_alman%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2621048790&rft_id=info:pmid/33777430&rfr_iscdi=true |